Christian Lang, MD, is a clinical resident at the Department of Medicine II, Division of Pulmonology, Medical University of Vienna, Austria. He is also pursuing his MD-PhD at the Translational Thoracic Oncology Laboratory, Department of Thoracic Surgery at the Medical University of Vienna.

• Thoracic Oncology
• Interventional Pulmology
• Lung translantation
• Critical Care

• Ferencz B, (…), Lang C et al. Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms. Cancer Immunology and Immunotherapy. 2024; doi10.1007/s00262-024-03704-7
• Solta A, (...), Lang C et al. Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer. Molecular Cancer. 2024; doi:10.1186/s12943-024-01953-9
• Lang C, Megyesfalviet al. C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer. World Journal of Surgical Oncology. 2024; doi:10.1186/s12957-024-03315-7
• Horvath L*, Lang C*, et al. Potential subtype-specific therapeutic approaches in small cell lung cancer. Current Opinion in Oncology. 2023; doi:10.1097/CCO.0000000000001005 *contributed equally as first-authors
• Solta A, (...), Lang C et al. Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair. Clinical Cancer Research. 2023; doi:10.1158/1078-0432.CCR-23-1795
• Megyesfalvi Z, (...), Lang C et al. Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies. Cancer Cell. 2023; doi:1016/j.ccell.2023.08.007
• Megyesfalvi Z, (...), Lang C et al. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. Cancer Journal for Clinicians. 2023 Jun 17; doi:10.3322/caac.21785
• Ferencz B, (...), Lang C et al. Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms. Lung Cancer. 2023; doi:10.1016/j.lungcan.2023.107263
• Valko Z, (…), Lang C et al. Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer. British Journal of Cancer. 2023; doi:10.1038/s41416-023-02219-9
• Lang C, Lantos A et al. Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer. ESMO Open. 2022; doi:10.1016/j.esmoop.2022.100631
• Szeitz B, (…), Lang Cet al. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer. Clinical and Translational Medicine. 2022; doi.org/10.1002/ctm2.1060
• Schwarz S, Lang Cet al. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS. The Journal of Heart and Lung Transplantation. 2022; doi:10.1016/j.healun.2022.06.020
• Lang C, Egger Fet al. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: an international multicenter analysis. Lung Cancer.2022; doi: 10.1016/j.lungcan.2022.05.010
• Megyesfalvi Z, (…). Lang Cet al. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer: an international multicenter study. Journal of Pathology. 2022; doi: 10.1002/path.5922
• Lang C, Ritschl Vet al. Clinical relevance of lung transplantation for COVID-19 ARDS: a nationwide study. European Respiratory Journal. 2022; doi: 10.1183/13993003.02404-2021
• Barany N, (…)Lang Cet al. Clinical relevance of circulating activin A and follistatin in small cell lung cancer. Lung Cancer. 2021; doi: 10.1016/j.lungcan.2021.09.008
• Bharat A, (…) Lang Cet al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. The Lancet Respiratory Medicine. 2021; doi: 10.1016/S2213-2600(21)00077-1
• Schwendenwein A, (…). Lang Cet al. Molecular profiles of small cell lung cancer subtypes: therapeutic implications. Molecular TherapyOncolytics. 2021; doi: 10.1016/j.omto.2021.02.004
• Megyesfalvi Z, (…). Lang Cet al. The landscape of small cell lung cancer metastases: Organ specificity and timing. Thoracic Cancer. 2021; doi: 10.1111/1759-7714.13854
• Ghimessy A, (…), Lang Cet al. Current therapy of KRAS-mutant lung cancer. Cancer Metastasis Review. 2020; doi: 10.1007/s10555-020-09903-9
• Lang C*, Jaksch P*et al. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient. The Lancet Respiratory Medicine. 2020; doi: 10.1016/S2213-2600(20)30361-1 *contributed equally as first-authors
• Megyesfalvi Z, (…), Lang Cet al. Heterogeneity of small cell lung cancer: biological and clinicopathological implications. MagyOnkologia.2020; PMID: 34608895
• Lang C, Hoetzenecker K, T Schweiger. Emerging biomarkers in pulmonary metastasectomy. Journal of Visualized Surgery. 2019; doi: 10.21037/jovs.2019.03.20
• Lang C*, Hrdliczka E*et al.Impact of cyclooxygenase-2 and prostaglandin-E2 expression on clinical outcome after pulmonary metastasectomy. Journal of Thoracic Disease. 2017; doi: 10.21037/jtd.2017.02.83 *contributed equally as first-authors

No content available to display!!!

• https://loop.frontiersin.org/people/2413162